# Lakewood-Amedex Biotherapeutics Inc.: Form 8-K, filed Jun 17, 2026

- Company: [Lakewood-Amedex Biotherapeutics Inc.](/companies/labt.md) (CIK 2079272)
- Form: 8-K
- Filed: 2026-06-17
- Accepted by EDGAR: Jun 17, 2026, 11:40 ET
- Period: 2026-06-15
- Accession: 0001213900-26-069512
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2079272/000121390026069512/ea0294845-8k_lakewood.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2079272/000121390026069512/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2079272/000121390026069512/ea0294845-8k_lakewood.htm

Filed Jun 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-069512. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.